{"schema_version":"1","generated_at":"2026-11-02T14:08:54.452Z","data_as_of":null,"url":"https://www.findmykol.com/kol/eric-christenson","json_url":"https://www.findmykol.com/kol/eric-christenson/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"eric-christenson","name":"Eric Christenson","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Johns Hopkins University","institution_url":"https://www.findmykol.com/institution/johns-hopkins-university-school-of-medicine","city":"Baltimore","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1043553456","orcid":"0000-0001-5261-6083","openalex":"A5049837751"},"summary":"Eric Christenson is an Oncology physician affiliated with Johns Hopkins University. OpenAlex indexes 132 publications with 1,272 citations (h-index 17); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":132,"cited_by_count":1272,"h_index":17,"latest_activity_year":2026,"emerging":true,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07580339","title":"Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT07580339","trial_url":"https://www.findmykol.com/trial/NCT07580339"},{"nct":"NCT07281768","title":"Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT07281768","trial_url":"https://www.findmykol.com/trial/NCT07281768"},{"nct":"NCT06782932","title":"Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT06782932","trial_url":"https://www.findmykol.com/trial/NCT06782932"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Boston Scientific Corporation","program_year":2025,"amount_usd":5765.5,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043553456"},{"payer":"ROCHE SEQUENCING SOLUTIONS, INC.","program_year":2025,"amount_usd":1000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043553456"},{"payer":"Takeda Pharmaceuticals U.S.A., Inc.","program_year":2025,"amount_usd":125,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043553456"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1043553456","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":100,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":14.2,"facility_pct":85.8},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2026,"last":2026},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA197296","title":"Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial","fiscal_year":2026,"amount_usd":"580237","organization":"JOHNS HOPKINS UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA197296"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-25-0002","status":"verified"},{"title":"Bispecific innate cell engager (ICE) AFM24 in combination with atezolizumab in patients with advanced/metastatic <i>EGFR</i> -expressing non-small cell lung cancer (NSCLC) without driver mutations: Initial results from a phase 2a study.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.2609","status":"verified"},{"title":"Ablating UNG activity in a mouse model inhibits colorectal cancer growth by increasing tumor immunogenicity","year":2025,"journal":"JCI Insight","source_url":"https://doi.org/10.1172/jci.insight.184435","status":"verified"},{"title":"Abstract CT264: Mutant KRAS peptide vaccine combined with ipilimumab/nivolumab in advanced mismatch repair proficient/microsatellite stable (MMRp/MSS) colorectal cancer: Preliminary analysis from a phase I study","year":2025,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2025-ct264","status":"verified"},{"title":"Sustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and Chemotherapy","year":2025,"journal":"The American Surgeon","source_url":"https://doi.org/10.1177/00031348251341945","status":"verified"}],"source":"works"},"contact":{"address_1":"600 N WOLFE ST","city":"Baltimore","state":"MD","zip":"212870005","phone":"410-955-7911","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1043553456","source":"identity"},"similar":[{"name":"Daniel Laheru","slug":"daniel-laheru","institution":"Johns Hopkins University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/daniel-laheru","json_url":"https://www.findmykol.com/kol/daniel-laheru/profile.json"},{"name":"Demosthenes G. Katritsis","slug":"demosthenes-katritsis","institution":"Johns Hopkins University","url":"https://www.findmykol.com/kol/demosthenes-katritsis","json_url":"https://www.findmykol.com/kol/demosthenes-katritsis/profile.json"},{"name":"Tanguy Seiwert","slug":"tanguy-seiwert","institution":"Johns Hopkins University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/tanguy-seiwert","json_url":"https://www.findmykol.com/kol/tanguy-seiwert/profile.json"},{"name":"Evan Lipson","slug":"evan-lipson","institution":"Johns Hopkins University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/evan-lipson","json_url":"https://www.findmykol.com/kol/evan-lipson/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-09-20","provider_certified":"2022-09-20","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}